The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials
Pfizer
Pfizer
Pfizer
BeOne Medicines
AstraZeneca
Boehringer Ingelheim
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Bristol-Myers Squibb
Allist Pharmaceuticals, Inc.
Seagen Inc.
Incyte Corporation
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Johnson & Johnson Enterprise Innovation Inc.
Revolution Medicines, Inc.
Eli Lilly and Company
Pfizer
D3 Bio (Wuxi) Co., Ltd
Novartis
Merck Sharp & Dohme LLC
Alterome Therapeutics, Inc.
Verastem, Inc.
Hoffmann-La Roche
Astellas Pharma Inc
Quanta Therapeutics
Treeline Biosciences, Inc.
R-Pharm
R-Pharm
Pfizer
Incyte Corporation
Chugai Pharmaceutical
Tizona Therapeutics, Inc
Novartis
Mirati Therapeutics Inc.
Genentech, Inc.
Merck Sharp & Dohme LLC
Revolution Medicines, Inc.
FBD Biologics Limited
Revolution Medicines, Inc.
Pfizer
Shandong Suncadia Medicine Co., Ltd.
Boehringer Ingelheim
Sanofi
Shanghai Institute Of Biological Products
Jacobio Pharmaceuticals Co., Ltd.
Pfizer
Chugai Pharmaceutical
Quanta Therapeutics
Incyte Corporation
Bristol-Myers Squibb
Bristol-Myers Squibb